Anti-Apo-D antibody [EPR22967-72]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal Apo-D antibody. Suitable for IP, WB, IHC-P and reacts with Human samples. Cited in 5 publications.
View Alternative Names
Apolipoprotein D, Apo-D, ApoD, APOD
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Apo-D antibody [EPR22967-72] (AB256496)
Immunohistochemical analysis of paraffin-embedded Human breast cancer tissue labeling Apo-D with ab256496 at 1/2000 dilution (0.35ug/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining in human breast cancer (PMID : 18330697, 18505051). Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Apo-D antibody [EPR22967-72] (AB256496)
Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling Apo-D with ab256496 at 1/2000 dilution (0.35ug/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Positive staining in stromal cells of human colon (PMID : 23296401). Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
- IP
Unknown
Immunoprecipitation - Anti-Apo-D antibody [EPR22967-72] (AB256496)
Apo-D was immunoprecipitated from 0.35 mg Human plasma lysate with ab256496 at 1/40 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab256496 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : Human plasma lysate 10ug
Lane 2 : ab256496 IP in Human plasma lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab256496 in Human plasma lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds.
All lanes:
Immunoprecipitation - Anti-Apo-D antibody [EPR22967-72] (ab256496)
Predicted band size: 21 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-Apo-D antibody [EPR22967-72] (AB256496)
Apo-D was immunoprecipitated from 0.35 mg Human placenta lysate with ab256496 at 1/40 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab256496 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : Human placenta lysate 10ug
Lane 2 : ab256496 IP in Human placenta lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab256496 in Human placenta lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-Apo-D antibody [EPR22967-72] (ab256496)
Predicted band size: 21 kDa
false
- WB
Lab
Western blot - Anti-Apo-D antibody [EPR22967-72] (AB256496)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The smeared bands between 22-35 kDa are mainly caused by different levels of glycosylation (PMID : 26829325).
Exposure time : Lane 1 : 26 seconds; Lanes 2-3 : 3 minutes.
All lanes:
Western blot - Anti-Apo-D antibody [EPR22967-72] (ab256496) at 1/1000 dilution
Lane 1:
Human plasma at 20 µg
Lane 2:
Human heart tissue lysate at 20 µg
Lane 3:
Human kidney tissue lysate at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 21 kDa
Observed band size: 22-35 kDa
false
Related conjugates and formulations (1)
-
Anti-Apo-D antibody [EPR22967-72] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Apo-D interacts with various molecules affecting lipid and cholesterol transport and metabolism. Apo-D operates as part of a protein complex and binds ligands such as progesterone and arachidonic acid. These interactions suggest it might modulate their availability and activity in biological systems. Furthermore the role of Apo-D in protecting cells against oxidative stress emerges as an important mechanism of action contributing to its protective properties in neural and other tissues.
Pathways
Apo-D plays significant roles by influencing the HDL (high-density lipoprotein) metabolism pathway and the arachidonic acid pathway. Within the HDL pathway Apo-D associates with other apolipoproteins like apoA-I to regulate cholesterol transport and anti-inflammatory responses. Its involvement in the arachidonic acid pathway suggests a possible regulatory effect on inflammation and cellular stress responses highlighting the complex interaction of Apo-D with other proteins like cyclooxygenases which are key players in inflammation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Cell reports. Medicine 6:102024 PubMed40107247
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell proliferation 58:e13818 PubMed39902627
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 12: PubMed39767614
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 4:101277 PubMed37944531
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in genetics 13:686739 PubMed35601482
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com